AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-110519878/sexual-dysfunction-drug-maker.html" title="Facts and information about Sexual dysfunction drug maker completes $2M financing.">Sexual dysfunction drug maker completes $2M financing.</a>
Close
Set up an RSS feed that alerts you when new articles from Women's Health Weekly are available.
Frequently asked questions about RSS feeds
Sexual dysfunction drug maker completes $2M financing.
2003 DEC 4 - (NewsRx.com & NewsRx.net) -- Enhance Biotech, Inc., (EBOI) announced that the company has completed a private equity financing of $2.0 million through the sale of common stock and warrants.
The company will be using these funds to accelerate the development of its lead products. This investment will enable Enhance to achieve significant milestones in its lead development programs over the next 3 to 5 months, including completing a phase IIa trial in premature ejaculation and the commencement of significant new clinical programs for the ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Pregnancy-test maker completes private placement.
- Magazine article from: Women's Health Weekly March 11, 2004 700+ words
...ovulation test market and the professional rapid diagnostic test market. This article was prepared by Women's Health Weekly editors from staff and other reports. Copyright 2004, Women's Health Weekly via NewsRx.com & NewsRx.net.
- CVProfilor maker completes $2.75M equity financing announced in August 2003.
- Newspaper article from: Cardiovascular Week March 8, 2004 700+ words
2004 MAR 8 - (NewsRx.com & NewsRx.net) -- Hypertension Diagnostics, Inc., (HDII) has raised $461,370, completing the $2.75 million funding announced in August 2003. The capital will be used to expand market penetration of the CVProfilor DO-2020 in the United States, HDI's medical device that,
- Veronate maker completes $20 million private placement.
- Newspaper article from: Anti-Infectives Week February 9, 2004 700+ words
2004 FEB 9 - (NewsRx.com & NewsRx.net) -- Inhibitex, Inc., has raised $20 million through a private placement of series E convertible preferred stock to existing investors, including New Enterprise Associates (NEA), William Blair Capital Partners, Alliance Technology Ventures, Burrill
- StaphVAX maker completes common stock offering.
- Newspaper article from: Vaccine Weekly January 28, 2004 700+ words
2004 JAN 28 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) announced the successful completion of its underwritten common stock offering. A total of 9.775 million shares were issued and net proceeds after expenses from this transaction generated approximately $92 million.
- Device maker completes $3M offering to stockholders.
- Newspaper article from: Health & Medicine Week May 24, 2004 700+ words
2004 MAY 24 - (NewsRx.com & NewsRx.net) -- Diomed Holdings, Inc., (DIO) announced that it has successfully completed its offering to those persons who held shares of its common stock on August 29, 2003, raising approximately $3.0 million in additional equity financing. "Given the company's
- GED maker completes $20M private financing; will advance clinical development.
- Newspaper article from: Biotech Week May 12, 2004 700+ words
2004 MAY 12 - (NewsRx.com & NewsRx.net) -- Inotek Pharmaceuticals Corp. announced that it has raised $20 million in a series A preferred stock financing led by Care Capital, LLC, Rho Ventures, and MedImmune Ventures, Inc. Inotek's products are based on a technology platform that targets
- Cubicin maker completes $120 million financing.
- Newspaper article from: Biotech Business Week December 27, 2004 700+ words
2004 DEC 27 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced the completion of its public offering of 9,316,700 shares of Cubist common stock at $11.20 per share. The company also announced that the underwriters of this offering exercised in full their option to
- Bearings maker completes consolidation into Oxford, Conn., base.
- Newspaper article from: Knight Ridder/Tribune Business News December 10, 2004 700+ words
By David A. Smith, Waterbury Republican-American, Conn. Knight Ridder/Tribune Business News Dec. 10--Roller Bearing Co. of America Inc. said Thursday it has set up shop in its new Oxford headquarters, less than six months after announcing it would consolidate two operations there. About 130 people
Source: HighBeam Research, Sexual dysfunction drug maker completes $2M financing.